ASND

Ascendis Pharma A/S

Price

$243.34

return (12m)

39.47%

p/e

26.47

p/bv

26.83

DIVIDEND YIELD

0.00%

ASND price

Ascendis Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ASND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.35%

3 months

8.02%

1 year

39.47%

2 years

83.99%

5 years

95.23%

10 years

1,589.86%

Fundamentals ASND

Valuation

P/E

26.47

Sector -3.98

Industry -3.98

P/BV

26.83

Sector 2.00

Industry 2.00

P/Revenue (PSR)

15.02

Sector -4.41

Industry -4.41

EV/EBITDA

554.01

Sector -245.01

Industry -245.01

EV/EBIT

676.32

Sector -666.51

Industry -666.51

P/EBITDA

-1,324.19

Sector -4.07

Industry -4.07

P/EBIT

-478.36

Sector -4.24

Industry -4.24

P/Total Assets

6.54

Sector 1.40

Industry 1.40

P/Net Current Assets

-33.32

Sector -11.65

Industry -11.65

P/Working Capital

-2,956.14

Sector -10.95

Industry -10.95

EPS

9.22

Sector -2.20

Industry -2.20

BVPS

9.10

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

89.05%

Sector 36.05%

Industry 36.05%

EBITDA Margin

9.45%

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

7.74%

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

-1.18%

Sector -38.74%

Industry -38.74%

Net Profit Margins

56.74%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.12

Sector 0.03

Industry 0.03

Profitability

ROE

101.37%

Sector -66.41%

Industry -66.41%

ROA

24.69%

Sector -66.55%

Industry -66.55%

ROIC

0.00%

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.00

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-8.02

Sector -14.63

Industry -14.63

Net Debt / EBIT

-9.78

Sector -7.24

Industry -7.24

Net Debt / Equity

-0.38

Sector -33,201.65

Industry -33,201.65

Gross Debt / Equity

0.79

Sector -0.02

Industry -0.02

Equity/Assets

0.24

Sector 0.42

Industry 0.42

Liabilities/Assets

0.76

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

157.17%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Ascendis Pharma ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$243.34

Fair Value

$43.45

Upside Return potential.

-82.14%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ASND

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ASND	26.47	26.83	101.37%	0.00%	$15.14 B	56.74%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	71.07	0.00	-%	2.66%	$448.43 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ASND Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ascendis Pharma

Ascendis Pharma A/S

Average Investor10 user rating

4.0 (5 people)

United States

20 years

Founded: 2006

2015

Time since IPO - 11 years

482

Employees

Ascendis Pharma A/S (United States) is listed on the Nasdaq and has a market capitalization of $15.14 billion, with shareholders equity totaling $564.13 million.

The company employs approximately 482 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ascendis Pharma A/S reported $1.01 billion in revenue, generating net income of $571.87 million.

Key financial metrics include a P/E ratio of 26.47, a price-to-book (P/B) ratio of 26.83, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ASND.

Market cap

$15.14 billion

Net worth

$564.13 million

$564,130,000.00

Assets

$2.32 billion

$2,315,930,000.00

Total Shares Outstanding

62.00 million

62,000,000

Average Daily Trading Volume

$699.19 Thousand

$699,192.94

Sector

Health Care

Industry

Biotechnology

ASND

ASND revenue and profits

Financial Results ASND

DRAG THE FRAME TO SEE MORE DATA

ASND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$827.14 16,95% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$235.60 50,09% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$254.41 53,26% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$245.10 29,37% (12M)

P/E

71.07

2.66%

ROE

P/BV

0.00

MRK - Merck & Co.

$127.77 66,38% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$157.97 8,58% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$47.09 4,55% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$827.14 16,95% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$235.60 50,09% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$254.41 53,26% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$245.10 29,37% (12 M)

P/L

71.07

2.66%

ROE

P/VP

0.00

MRK - Merck & Co.

$127.77 66,38% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$157.97 8,58% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$47.09 4,55% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Ascendis Pharma (ASND) today?

A cotação de Ascendis Pharma (ASND) hoje está em US$ 243.34, com uma variação de 39.47% em relação ao último ano. A cotação de Ascendis Pharma (ASND) iniciou o ano negociando na casa dos US$ 213.24 e hoje está em US$ 243.34. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Ascendis Pharma (ASND) e dados de ações do Ibovespa e mercados internacionais.

Quando Ascendis Pharma (ASND) paga dividendos?

Ascendis Pharma (ASND) não distribuiu dividendos no último ano.

Is Ascendis Pharma (ASND) a good investment?

Atualmente, Ascendis Pharma (ASND) está cotada a US$ 243.34, com um P/L de 26.47, representando um desvio de -1,390% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 39.47 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 39.47%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ascendis Pharma (ASND) stock?

Investir em ações de Ascendis Pharma (ASND) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Ascendis Pharma (ASND) yield today?

A rentabilidade de Ascendis Pharma (ASND) foi de -11.35% no último mês, 39.47% no último ano e 95.23% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Ascendis Pharma (ASND) hoje, o investimento total seria de US$ 24,334.00, com base na cotação atual de US$ 243.34.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 33,938.63
Em 5 anos: US$ 47,507.27
Em 10 anos: US$ 411,210.53

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ASND

Ascendis Pharma A/S

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ASND

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Ascendis Pharma

Ascendis Pharma A/S

United States

20 years

2015

482

PROFIT X PRICE ASND

Financial Results ASND

ASND cash flow

Asset, Revenue and Profit Growth - ASND

ASND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions